Physiol Rev Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Rev. 79: 1227-1282, 1999;
0031-9333/99 $15.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zicha, J.
Right arrow Articles by Kunes, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zicha, J.
Right arrow Articles by Kunes, J.

Physiological Reviews, Vol. 79, No. 4, October 1999, pp. 1227-1282
Copyright ©1999 by the American Physiological Society

Ontogenetic Aspects of Hypertension Development: Analysis in the Rat

Josef Zicha and Jaroslav Kunes

Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic

Zicha, Josef and Jaroslav Kunes. Ontogenetic Aspects of Hypertension Development: Analysis in the Rat. J. Neurophysiol. 79: 1227-1282, 1999. In this review, we attempt to outline the age-dependent interactions of principal systems controlling the structure and function of the cardiovascular system in immature rats developing hypertension. We focus our attention on the cardiovascular effects of various pharmacological, nutritional, and behavioral interventions applied at different stages of ontogeny. Several distinct critical periods (developmental windows), in which particular stimuli affect the further development of the cardiovascular phenotype, are specified in the rat. It is evident that short-term transient treatment of genetically hypertensive rats with certain antihypertensive drugs in prepuberty and puberty (at the age of 4-10 wk) has long-term beneficial effects on further development of their cardiovascular apparatus. This juvenile critical period coincides with the period of high susceptibility to the hypertensive effects of increased salt intake. If the hypertensive process develops after this critical period (due to early antihypertensive treatment or late administration of certain hypertensive stimuli, e.g., high salt intake), blood pressure elevation, cardiovascular hypertrophy, connective tissue accumulation, and end-organ damage are considerably attenuated compared with rats developing hypertension during the juvenile critical period. As far as the role of various electrolytes in blood pressure modulation is concerned, prohypertensive effects of dietary Na+ and antihypertensive effects of dietary Ca2+ are enhanced in immature animals, whereas vascular protective and antihypertensive effects of dietary K+ are almost independent of age. At a given level of dietary electrolyte intake, the balance between dietary carbohydrate and fat intake can modify blood pressure even in rats with established hypertension, but dietary protein intake affects the blood pressure development in immature animals only. Dietary protein restriction during gestation, as well as altered mother-offspring interactions in the suckling period, might have important long-term hypertensive consequences. The critical periods (developmental windows) should be respected in the future pharmacological or gene therapy of human hypertension.




This article has been cited by other articles:


Home page
J. Physiol.Home page
A. E. Simms, J. F. R. Paton, A. E. Pickering, and A. M. Allen
Amplified respiratory-sympathetic coupling in the spontaneously hypertensive rat: does it contribute to hypertension?
J. Physiol., February 1, 2009; 587(3): 597 - 610.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
H. Hwang, R. A. Kloner, M. T. Kleinman, and B. Z. Simkhovich
Direct and Acute Cardiotoxic Effects of Ultrafine Air Pollutants in Spontaneously Hypertensive Rats and Wistar--Kyoto Rats
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2008; 13(3): 189 - 198.
[Abstract] [PDF]


Home page
HypertensionHome page
N. H. Lee, B. J. Haas, N. E. Letwin, B. C. Frank, T. V. Luu, Q. Sun, C. D. House, S. Yerga-Woolwine, P. Farms, E. Manickavasagam, et al.
Cross-Talk of Expression Quantitative Trait Loci Within 2 Interacting Blood Pressure Quantitative Trait Loci
Hypertension, December 1, 2007; 50(6): 1126 - 1133.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Opocensky, H. J. Kramer, A. Backer, Z. Vernerova, V. Eis, L. Cervenka, V. Certikova Chabova, V. Tesar, and I. Vaneckova
Late-Onset Endothelin-A Receptor Blockade Reduces Podocyte Injury in Homozygous Ren-2 Rats Despite Severe Hypertension
Hypertension, November 1, 2006; 48(5): 965 - 971.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
L. J. Mullins, M. A. Bailey, and J. J. Mullins
Hypertension, Kidney, and Transgenics: A Fresh Perspective
Physiol Rev, April 1, 2006; 86(2): 709 - 746.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
R. Villalobos-Molina and M. Ibarra
Increased Expression and Function of Vascular {alpha}1D-Adrenoceptors May Mediate The Prohypertensive Effects Of Angiotensin II
Mol. Interv., December 1, 2005; 5(6): 340 - 342.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. Vaneckova, H. J. Kramer, A. Backer, Z. Vernerova, M. Opocensky, and L. Cervenka
Early Endothelin-A Receptor Blockade Decreases Blood Pressure and Ameliorates End-Organ Damage in Homozygous Ren-2 Rats
Hypertension, October 1, 2005; 46(4): 969 - 974.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Miquel, R. Gisbert, E. Serna, F. Perez-Vizcaino, E. Anselmi, M. A. Noguera, M. D. Ivorra, and M. P. D'Ocon
Acute and Chronic Captopril, but Not Prazosin or Nifedipine, Normalize Alterations in Adrenergic Intracellular Ca2+ Handling Observed in the Mesenteric Arterial Tree of Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 359 - 367.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Racasan, B. Braam, H. A. Koomans, and J. A. Joles
Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon
Am J Physiol Renal Physiol, April 1, 2005; 288(4): F626 - F636.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Schwartz and J. L. Morrison
Impact and mechanisms of fetal physiological programming
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R11 - R15.
[Full Text] [PDF]


Home page
HypertensionHome page
J.-C. Zhong, D.-Y. Huang, Y.-M. Yang, Y.-F. Li, G.-F. Liu, X.-H. Song, and K. Du
Upregulation of Angiotensin-Converting Enzyme 2 by All-trans Retinoic Acid in Spontaneously Hypertensive Rats
Hypertension, December 1, 2004; 44(6): 907 - 912.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
D. L. Mattson, M. P. Kunert, M. L. Kaldunski, A. S. Greene, R. J. Roman, H. J. Jacob, and A. W. Cowley Jr
Influence of diet and genetics on hypertension and renal disease in Dahl salt-sensitive rats
Physiol Genomics, January 15, 2004; 16(2): 194 - 203.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
P. Sparen, D. Vagero, D. B Shestov, S. Plavinskaja, N. Parfenova, V. Hoptiar, D. Paturot, and M. R. Galanti
Long term mortality after severe starvation during the siege of Leningrad: prospective cohort study
BMJ, January 3, 2004; 328(7430): 11.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. J. Swoap, D. Weinshenker, R. D. Palmiter, and G. Garber
Dbh(-/-) mice are hypotensive, have altered circadian rhythms, and have abnormal responses to dieting and stress
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2004; 286(1): R108 - R113.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. C. Chappell, P. E. Gallagher, D. B. Averill, C. M. Ferrario, and K. B. Brosnihan
Estrogen or the AT1 Antagonist Olmesartan Reverses the Development of Profound Hypertension in the Congenic mRen2.Lewis Rat
Hypertension, October 1, 2003; 42(4): 781 - 786.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. ZICHA, C. D. NEGRIN, Z. DOBESOVA, F. CARR, M. VOKURKOVA, M. W. MCBRIDE, J. KUNES, and A. F. DOMINICZAK
Altered Na+-K+ pump activity and plasma lipids in salt-hypertensive Dahl rats: relationship to Atp1a1 gene
Physiol Genomics, July 17, 2001; 6(2): 99 - 104.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online